TigerGene is a venture capital firm established in 2018 and located in Cambridge, Massachusetts. The company focuses on investing in platform technology firms, particularly those within the life sciences sector, that have the potential to develop disruptive technologies and high-growth trajectories. By identifying and supporting innovative companies with strong intellectual property portfolios, TigerGene aims to foster advancements in technology that can significantly impact various industries.
Valora Therapeutics, based in San Diego, California, is a biotechnology company focused on the development of innovative biological drugs. It specializes in engineering chimeric antibodies, which are designed to harness the body's immune system to fight cancer and other diseases. The company operates at the pre-clinical stage, working to unlock new mechanisms of immune signaling and activity, with the aim of providing transformative therapies to the healthcare industry.
NanoMosaic
Series A in 2021
NanoMosaic is a biotechnology company focused on advancing early illness detection, prognostic monitoring, and biomarker identification through its innovative nanoneedle technology. The company's proprietary proteomic platform utilizes nanoneedles to enable precise protein detection and quantification. By integrating these capabilities onto a single chip, NanoMosaic aims to enhance the efficiency and accuracy of biomarker discovery and validation processes. This technology is designed to support the medical and healthcare industries in improving diagnostic capabilities and patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.